Načítá se...
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Atrial fibrillation and coronary artery disease are commonly coexisting conditions that necessitate the use of an oral anticoagulant as well as dual antiplatelet therapy. Commonly referred to as triple oral antithrombotic therapy (TT), this helps prevent ischemic stroke and myocardial infarction but...
Uloženo v:
| Vydáno v: | Avicenna J Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer - Medknow
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6796304/ https://ncbi.nlm.nih.gov/pubmed/31903386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ajm.AJM_73_19 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|